Following a national search, Dean Giuseppe Colasurdo has announced Dr. John Hancock as the executive director of the Medical School’s Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM).
April 29th, 4:00 PM, MSB 2.135
Qiang Tong, Ph.D.
Baylor College of Medicine
"Regulation of muscle function by SIRT2 and SIRT3 deacetylases"
May 6th, 4:00 PM, MSB 2.135
Darren Boehning, Ph.D.
University of Texas Medical Branch, Galveston
"Calcium & Death Receptor Signaling: Redefining the Fas/CD95 Pathway"
May 13th, 4:00 PM, MSB 2.135
Ben Collins, Ph.D.
New York University
"Multiple roles for glutamate signaling between circadian clock neurons"
May 2nd, 2013
CRB Group Meeting
12:00pm-1:00pm, MSB 4.100
The Department of Integrative Biology and Pharmacology (IBP) is interested in the cell biology, physiology and pharmacology of cell regulation and communication. Our major research themes include the molecular mechanisms and spatiotemporal dynamics of membrane signaling, intracellular and metabolic signaling, the biology and physiology of cell-cell interactions, and the use of computational, structural and systems approaches to decipher signaling networks. These efforts are aimed at understanding how normal and abnormal cell function translates into whole animal physiology and pathophysiology, and exploring the molecular pharmacology of existing and novel therapeutics. In this context, IBP has research programs in cancer cell biology, cardiovascular biology, tissue regeneration and plasticity (especially in nerve and muscle), and neuronal signaling in injury, inflammation and pain. We also investigate GI and renal physiology. Our investigators make extensive use of a wide range of genetically tractable model organisms including: mice, Drosophila, Zebrafish, Aplysia and Arabidopsis; they use computational techniques, including classical and advanced molecular dynamics simulations, structural bioinformatics and novel bioinformatic approaches to interrogate gene expression data sets; as well as contemporary molecular cell biology, biochemistry and electrophysiology.
IBP has recently undergone a major expansion with the recruitment of fourteen new faculty since 2008. We have also completed a total renovation of all of our laboratories on the 4th floor of the Medical School and occupied new space on the 3rd floor of the Medical School Research Building. IBP has established a new, purpose-built, advanced cell-imaging facility that provides for confocal, TIRF, wide-field and confocal FLIM microscopy, high content screening as well as an IVIS system for small animal imaging. In addition there is a new departmental core for electrophysiology. Research in IBP is further supported by outstanding core facilities located within the Medical School for microarray analysis, proteomics, high throughput siRNA and drug screening, high throughput real-time qPCR, DNA sequencing, SNP analysis, and high throughput quantitative ELISA.
IBP faculty teach Physiology and Pharmacology to medical and dental students. We run an active graduate studies program in Cell and Regulatory Biology and we participate in the University Centers for Membrane Biology and Clinical and Translation Sciences within the Medical School and in several training grants including those in Pharmacological Sciences and Computational Cancer Biology.
John Hancock, Chairman
VIEW OUR LATEST DEPARTMENTAL NEWSLETTER HERE!